Marketing-authorisation holder · United States
Merck & Co., Inc.
75 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
75 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 75
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALDOCLOR-150150mg; 250mg · Tablet | Chlorothiazide, Methyldopa | United States | Not marketed | 1968 |
| ALDOCLOR-250250mg; 250mg · Tablet | Chlorothiazide, Methyldopa | United States | Not marketed | 1968 |
| ALDOMET125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Methyldopa | United States | Not marketed | 1962 |
| ALDOMET250mg/5ml · Suspension | Methyldopa | United States | Not marketed | 1981 |
| ALDOMET50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Methyldopa | United States | Not marketed | 1962 |
| ALDORIL 1515mg; 250mg · Tablet | Hydrochlorothiazide, Methyldopa | United States | Not marketed | 1962 |
| ALDORIL 2525mg; 250mg · Tablet | Hydrochlorothiazide, Methyldopa | United States | Not marketed | 1962 |
| ALDORIL D3030mg; 500mg · Tablet | Hydrochlorothiazide, Methyldopa | United States | Not marketed | 1962 |
| ALDORIL D5050mg; 500mg · Tablet | Hydrochlorothiazide, Methyldopa | United States | Not marketed | 1962 |
| ALPHAREDISOL1mg/ml · Injectable | Hydroxocobalamin | United States | Not marketed | 1975 |
| AMINOHIPPURATE SODIUM20% · Injectable | Aminohippuric acid | United States | Not marketed | 1944 |
| ARAMINE10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Metaraminol | United States | Not marketed | 1954 |
| BENEMID500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Probenecid | United States | Not marketed | 1951 |
| BLOCADREN10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Timolol | United States | Not marketed | 1981 |
| CANCIDAS50mg/vial | 70mg/vial · Powder | Caspofungin | United States | Not marketed | 2001 |
| CHIBROXIN0.3% · Solution/drops | Norfloxacin | United States | Not marketed | 1991 |
| CLINORIL150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Sulindac | United States | Not marketed | 1978 |
| COGENTIN0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Benzatropine | United States | Not marketed | 1954 |
| COLBENEMID0.5MG; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Colchicine, Probenecid | United States | Not marketed | 1961 |
| CORTONE25mg/ml | 50mg/ml · Injectable | Cortisone | United States | Not marketed | 1950 |
| CORTONE25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Cortisone | United States | Not marketed | 1950 |
| CYCLAINE5% · Solution | Hexylcaine | United States | Not marketed | |
| DECADERM0.1% · GEL | Dexamethasone | United States | Not marketed | |
| DECADRON0.1% PHOSPHATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Dexamethasone | United States | Not marketed | 1959 |
| DECADRON0.5mg/5ml · Elixir | Dexamethasone | United States | Not marketed | 1960 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 75 | 75 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
US Securities and Exchange Commission, EDGAR / Merck & Co., Inc., CIK 0000310158; exact US-GAAP tag, period, unit, accession number and filing date. Retrieved 8 October 2026. Structured annual-fact selection by Prognia.
Licence: SEC documented public-data and EDGAR filing-content reuse permission
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.